Celebrating 100 Years of Scripps Research
La Jolla Playhouse takes great pride in celebrating 100 Years of Scripps Research at this year’s Innovation Night. Under the leadership of Peter Schultz, President and CEO of Scripps Research, they continue to build on this remarkable record to push the frontiers of science and medicine over the next century and beyond.
Scripps Research was founded in 1924 as the Scripps Metabolic Clinic in La Jolla with a gift from local philanthropist Ellen Browning Scripps. Inspired, in part, by the discovery of insulin in 1921 to treat diabetes, she believed that science would transform the field of medicine. The tremendous impact of Scripps Research over the past century has proven her right and today we carry on that tradition, continuing the institute’s rich history and achievements to push the frontiers of science and medicine over the next century and beyond.
The institute sets the standard for excellence in a number of research fields, evidenced by the steady stream of groundbreaking discoveries that emerge from the institute’s labs in chemistry, neuroscience, immunology and structural biology, to name a few. Building upon this foundation of scientific excellence, we’ve established a remarkable track record of generating new medicines. Discoveries made in the institute’s labs have enabled 15 FDA-approved therapies…with many more on the horizon.
Under the leadership of Peter Schultz, President and CEO of Scripps Research, we have begun to build on this remarkable record to establish a new paradigm for the institute and for the field of science more broadly.
Sponsors
WHO WE ARE
For nearly 160 years, we have been committed to providing our clients with great service and powerful financial expertise to help them meet their financial goals. PNC offers a wide range of services for all our customers, from individuals and small businesses, to corporations and government entities. No matter how simple or complicated your needs, we’re sure to have the products, knowledge and resources necessary for financial success.
WHY THIS EVENT?
On behalf of our entire team at PNC Bank, we are thrilled to be the presenting sponsor of this year’s Innovation Night.
For a third consecutive year, we are honored to partner with the incredible team at the La Jolla Playhouse to raise vital funds to support the next generation of American theatre as well as further the collaboration between artists and leaders of San Diego’s tech, defense and telecommunication industries.
For decades, PNC nationally has been a dedicated supporter of the arts on a national level. And since launching the San Diego market in 2021, we too have been passionate about supporting the arts all the while banking and extending capital to tech and life sciences sectors from Boston to the Bay.
It is for these reasons why we look forward to celebrating Innovation Night because it brings together two seemingly opposite domains – the Arts and the Sciences. Yet, they are two sides of the same coin. Domains that are built upon creativity, imagination, and innovation.
By investing in the arts, we – as a community – nurture cultural expression and individual identity. The stories that are told on the stage are the essence of our humanity as they broaden our mind, engage our body and move our spirit. Similarly, the sciences are crucial for the advancement and well-being of society like this year’s honoree Peter Schultz and Scripps Research which has developed groundbreaking pioneering discoveries that tackle global challenges and fuel economic growth.
WHO WE ARE
Clients partner with Cooley on transformative deals, complex IP and regulatory matters, and high-stakes litigation, where innovation meets the law. Cooley has 1,300+ lawyers across 19 offices in the United States, Asia and Europe
WHY THIS EVENT?
Cooley is proud to be a lead sponsor of La Jolla Playhouse’s Innovation Night because it reflects two of our key values: fostering innovation and giving back to our communities. We celebrate and embrace our ability to serve as a member of San Diego’s vibrant arts and tech community.
Founded as an experiment in 1960, UC San Diego scholars aren’t afraid to challenge convention if it means we can accelerate answers to our society’s most pressing issues. As one of the top 20 research universities in the world, we are driving change far beyond our walls to advance society and propel economic growth. And the world has taken notice.
UC San Diego’s main campus is located near the Pacific Ocean on approximately 1,200 acres of coastal woodland in La Jolla, California. The campus sits on the ancestral homelands of the Kumeyaay Nation. Kumeyaay people continue to have an important and thriving presence in the region. UC San Diego’s rich academic portfolio includes eleven academic, professional and graduate schools and eight undergraduate residential colleges. UC San Diego is also home to the prestigious Scripps Institution of Oceanography and the UC San Diego Health System.
WHO WE ARE
The Maravai LifeSciences Foundation seeks out opportunities to contribute to the improvement of human health. Our giving supports charitable, scientific, and educational endeavors, with particular emphasis on advancing scientific education and innovation, supporting local communities in which we operate, promoting public health and access to healthcare, and advocating for inclusion and diversity. The Maravai LifeSciences Foundation is a U.S.-based, private charitable foundation whose activities are made possible by contributions from Maravai LifeSciences. It is a separate legal entity from Maravai LifeSciences with distinct legal restrictions.
WHY THIS EVENT?
The Maravai LifeSciences Foundation is proud to once again support Innovation Night. From award-winning plays and musicals to imaginative programs for young audiences, to embracing artists of all backgrounds and abilities, the Playhouse brings people together to inspire discussion and open our minds to new ways of thinking. We celebrate the La Jolla Playhouse and the extraordinary impact they have on our community.
WHO WE ARE
The University of San Diego is a contemporary Catholic university, grounded in the liberal arts and anchored along an international border, advancing academic excellence to create a more inclusive, sustainable and hopeful world.
WHY THIS EVENT?
The University of San Diego is committed to inspiring and equipping future leaders and innovators who will make a positive impact on humanity and the planet. Through rigorous academic programs, hands-on learning experiences, and interdisciplinary collaboration, this mission comes to life. The La Jolla Playhouse’s Innovation Night embodies this commitment, providing our community of learners with opportunities to share fresh insights and connect with San Diego’s leading visionaries, who will help propel our students forward to serve both our region and the world. A special thank you to our very own trustee Tim Scott, JD ’96, and Andrew Biros for their leadership roles for this year’s Innovation Night.
WHO WE ARE
AustinPx, Pharmaceutics and Manufacturing is a contract development and manufacturing organization (CDMO) providing analytical and formulation development services and cGMP manufacturing for small molecule drugs. The Company specializes in phase-appropriate development strategies, speed to clinic and market strategies, and bioavailability enhancement of poorly soluble molecules – including its next generation amorphous dispersion platform, KinetiSol®.
WHY THIS EVENT?
Innovation Night is one of the best events of the year, bringing together the technology community and the arts community. Arts and Sciences are frequently listed together and rarely play together. Innovation Night is a special night when STEM becomes STEAM and the La Jolla Playhouse welcomes innovation companies to UCSD’s Theatre District to show off a bit of its own artful innovation. What makes this year’s event extra special is our honorary chair, Irwin Jacobs. As co-founder of Linkabit and Qualcomm, Irwin has created one of San Diego’s greatest entrepreneurial legacies, which is only surpassed by Irwin and Joan Jacobs contributions to our community and institutions, including the La Jolla Playhouse.
WHO WE ARE
The Carson Royston Group (CRG) is managed by Colette Carson Royston and Ivor Royston, long-time supporters of La Jolla Playhouse, with the unique mission of developing and supporting biopharmaceutical technology and the theatrical arts – two areas industries near and dear to Colette and Ivor.
WHY THIS EVENT?
Innovation is critical to the success of both science and theatre which provide enormous benefits to society. We salute the innovation and theatrical leadership in this country by pioneers such as honoree, Scripps Institute and La Jolla Playhouse, under the artistic leadership of Christopher Ashley.
WHO WE ARE
Latham & Watkins delivers innovative solutions to complex legal and business challenges around the world. From a global platform, our lawyers advise clients on market-shaping transactions, high-stakes litigation and trials, and sophisticated regulatory matters. Latham is one of the world’s largest providers of pro bono services, steadfastly supports initiatives designed to advance diversity within the firm and the legal profession, and is committed to exploring and promoting environmental sustainability.
Latham & Watkins draws on elite capabilities across more than 60 disciplines to meet the precise needs of each client and matter. This includes one of the most integrated and comprehensive healthcare and life sciences practices in the world, with more than 30 years of experience delivering sophisticated and practical guidance to a broad spectrum of healthcare and life sciences companies on their most complex regulatory, transactional, investigatory and litigation challenges. We work with clients at every stage of development, from start-ups to public companies, across a global platform enabling us to provide best-in-class advice.
WHY THIS EVENT?
It is our honor to partner with La Jolla Playhouse on Innovation Night in support of San Diego’s arts and sciences community and in celebration of 100 Years of Scripps Research.
» lw.com
WHO WE ARE
The Lodge at Torrey Pines is La Jolla’s AAA Five Diamond resort set alongside the Torrey Pines Golf Course and Torrey Pines State Natural Reserve. The Lodge pays homage to California Craftsman architecture and showcases 170 rooms and suites that were designed in harmony with the pristine surroundings. Earning the Readers’ Choice Award by Condé Nast Traveler, the luxury resort is home to The Spa at Torrey Pines and its signature restaurant A.R. Valentien with Executive Chef Kelli Crosson at the helm. The adjacent Torrey Pines Golf Course was the site of the 2008 and 2021 U.S Open Championships, and The Lodge is also a member of the California Green Lodging Program.
WHY THIS EVENT?
The Lodge has been a proud neighbor and seasoned sponsor of La Jolla Playhouse for over a decade. La Jolla Playhouse is one of the greatest American theaters of our time which has given the world Jersey Boys, Come From Away, and Escape to Margaritaville. We are proud to be part of Innovation Night 2024 to celebrate not just the Playhouse’s extraordinary work, but the contributors to society.
WHO WE ARE
Marsh McLennan Agency (MMA) provides business insurance, employee health & benefits, retirement, and private client insurance solutions to organizations and individuals seeking limitless possibilities. MMA combines the personalized service model of a local consultant with the global resources of the world’s leading professional services firm, Marsh McLennan (NYSE: MMC). With 10,000 colleagues and 170 offices across North America, including nine office locations in the West region: San Diego, Orange County, San Francisco, Walnut Creek, Los Angeles, Las Vegas, Scottsdale, Tucson, and Anchorage, we work together to bring clients the latest innovations in the insurance industry.
WHY THIS EVENT?
In looking toward the future, we firmly believe innovation is the main driver in revolutionizing insurance – as well as many of the industries we serve. As we seek out novel ways to better serve our colleagues, clients, and community, we dedicate ourselves to building meaningful relationships with those at the forefront of inspiring local change. Be it tech, medicine, or the wildly inventive arts of organizations such as La Jolla Playhouse, we are proud to serve and support those in the greater San Diego area who aim to help foster local economic growth – all while changing the world with bold, forward-thinking ideas.
WHO WE ARE
Qualcomm is enabling a world where everyone and everything can be intelligently connected. Our portfolio of leading innovations allows us to efficiently scale the technologies that launched the mobile revolution – including advanced connectivity, high-performance, low-power compute, on-device intelligence and more – to the next generation of connected smart devices across industries. Innovations from Qualcomm and our family of Snapdragon platforms will help enable cloud-edge convergence, transform industries, accelerate the digital economy, and revolutionize how we experience the world, for the greater good.
WHY THIS EVENT?
Qualcomm co-founder Irwin Jacobs’ passion for the arts, and giving back to the community, inspired the company’s executive sponsorship of the La Jolla Playhouse in 2000. We are thrilled to take part in Innovation night to demonstrate some of our latest technologies and learn from our community partners.
WHO WE ARE
The Division of Research and Innovation at San Diego State University fosters technology transfer from bench to business, cultivates university-industry partnerships and offers award-winning entrepreneurship training to students, faculty and alumni.
These initiatives will expand into the 1.6 million square feet of office, technology, laboratory and research space to be housed within the SDSU Mission Valley Innovation District. The Innovation District will convene transdisciplinary collaborations to solve big challenges in sustainability, cybersecurity, transportation and health equity.
WHY THIS EVENT?
Our SDSU representatives, including budding entrepreneurs and successful founders from our on-campus accelerator and incubator, are excited to connect and share their experiences with fellow innovators in our San Diego community.
» sdsu.edu
WHO WE ARE
Scripps Research is one of the world’s largest independent, nonprofit biomedical research organizations. For a century, our innovative faculty members have led investigations that expand fundamental knowledge in the biosciences and pave the way for new technologies and medicines. Across our six departments, scientists have made groundbreaking discoveries and originated over 15 FDA-approved medicines now benefiting patients. At our highly competitive Skaggs Graduate School of Chemical and Biological Sciences—ranked consistently among the nation’s top 10 since 1999 by U.S. News & World Report—Scripps Research faculty educate the next generation of leading scientists, equipping them to launch influential careers. As we look toward the next 100 years, we’re excited to harness our world-class research and translational capabilities to continue pioneering tremendous impacts on human health.
WHY THIS EVENT?
Since 1924, Scripps Research has championed creativity and innovation—be it from a laboratory bench or a theater stage—as keys to improving the human condition. It is our honor to partner with the La Jolla Playhouse on Innovation Night.
WHO WE ARE
VETmAb Bio is a veterinary biopharmaceutical company focused on developing best in class monoclonal antibody (“mAb”) therapeutics for dogs and cats to address unmet medical needs. Our mission is to develop for pets the same caliber of innovative, safe and effective medicines to which we have access. We are developing a pipeline of novel biologics across several autoimmune conditions.
WHY THIS EVENT?
Innovators are inspired by other innovators. At VETmAb Bio, we are a group of creative drug developers and protein engineers who are inspired by La Jolla Playhouse’s brave new works. We are honored to support Innovation Night to celebrate La Jolla Playhouse, a beacon of American theatre, as well as San Diego’s incredible innovation ecosystem.
WHO WE ARE
Scripps Institution of Oceanography at the University of California San Diego is one of the world’s most important centers for global earth science research and education. In its second century of discovery, Scripps scientists work to understand and protect the planet, and investigate our oceans, Earth, and atmosphere to find solutions to our greatest environmental challenges. Scripps offers unparalleled education and training for the next generation of scientific and environmental leaders through its undergraduate, master’s and doctoral programs. The institution also operates a fleet of four oceanographic research vessels, and is home to Birch Aquarium at Scripps, the public exploration center that welcomes 500,000 visitors each year.
WHY THIS EVENT?
Scripps Institution of Oceanography at UC San Diego is proud to support Innovation Night 2024. Scripps Oceanography salutes its fellow La Jolla institution, the La Jolla Playhouse. Both of us draw inspiration from and encourage the melding of art and science, which engage together speak to the breadth of humanity’s awareness with its home planet and beyond.
Schedule
5:30
Drinks and mingling
6:30
La Jolla Playhouse and PNC Bank videos
Tribute to Scripps Research
Remarks from Dr. Peter Schultz
6:45
Performance by SWAY
7:00
DJ Shammy Dee
A Letter from Christopher Ashley and Debby Buchholz
Welcome to La Jolla Playhouse’s Innovation Night 2024! We invite you to network with colleagues, peruse the gallery displays, enjoy delicious food and beverages, and experience globally renowned art at one of our biggest events of the year.
This year Innovation Night proudly honors 100 years of Scripps Research. Under the leadership of President and CEO Peter Schultz, Scripps Research is a pioneer of science and medicine. Tonight, we celebrate the countless discoveries that have taken shape in the Institute’s labs in medicine, chemistry, neuroscience, immunology and structural biology, to name a few, and we look forward to their future innovations. Scripps Research has always championed creativity and innovation; the incredible work they do to advance medicine and strive for scientific excellence is vital to human experience, just as much as art is.
Launched in 2007, Innovation Night raises vital funds to create the new and next in American theatre. Your generosity supports the Playhouse’s research and development efforts, which include our signature new play development programs, our Without Walls (WOW) series of immersive and barrier-breaking theatre, and ongoing artist commissions and residencies. We are proud of the partnerships that Innovation Night facilitates among artists and leaders in San Diego’s life sciences, biotech, high-tech, cleantech, defense and telecommunication industries.
We extend our deepest gratitude to Presenting Sponsor PNC Bank; Lead Sponsors BioMed Realty, Cooley and UC San Diego; and Host Sponsors Maravai LifeSciences, Show Imaging and University of San Diego. These supporters, along with the many others noted in this program, make a tremendous impact in our community and around the globe. Please join us in thanking them when you see their employees and members this evening.
On behalf of the Playhouse’s staff, artists and Board of Trustees, we extend a heartfelt thank you and congratulations to Scripps Research, our multifaceted Host Committee, as well as our dedicated and spirited Innovation Night 2024 Co-Chairs: Denise Bevers, President & CEO of VETmAb Biosciences; Adam Jacobs, Co-founder of The Jacobs Scheriff Group; and Tim Scott, President & CEO of AustinPx.
And finally, thank you for making our 17th annual Innovation Night an incredible success and for all that YOU do to make San Diego such a vibrant community.
About La Jolla Playhouse
La Jolla Playhouse is where artists and audiences come together to create what’s new and next in American Theatre. From Tony Award-winning plays and musicals, to imaginative programs for young audiences, to interactive experiences outside our theatre walls, the Playhouse brings people together to inspire discussion and open pathways to new ways of thinking. A visit to the Playhouse is an invitation to harness the transformative power of theatre to explore the here and now – and together, expand our world’s compassion, understanding and hope.
Our Mission
La Jolla Playhouse advances theatre as an art form, telling stories that inspire empathy and create a dialogue toward a more just future. With our intrepid spirit and eclectic, artist-driven approach we will continue to cultivate a local, national and global following with an insatiable appetite for audacious work.
We provide unfettered creative opportunities for a community of artists of all backgrounds and abilities. We are committed to being a permanent safe harbor for unsafe and surprising work, offering a glimpse of the new and the next in American theatre.
Leadership
Christopher Ashley
The Rich Family Artistic Director of La Jolla Playhouse
Tony Award-winner Christopher Ashley has served as La Jolla Playhouse’s Artistic Director since 2007. During his tenure, he directed the world premieres of Come From Away, Diana: The Musical, Memphis, Escape to Margaritaville, The Squirrels, A Dram of Drummhicit, Restoration and Chasing the Song, as well as His Girl Friday, Glengarry Glen Ross, A Midsummer Night’s Dream, Freaky Friday and Xanadu. He also spearheaded the Playhouse’s Without Walls (WOW) initiative, the DNA New Work Series and the Resident Theatre program.
Mr. Ashley recently directed Come From Away for AppleTV+ and Diana: The Musical for Netflix. Other screen credits include the feature films Jeffrey and Lucky Stiff, and the American Playhouse production of Blown Sideways Through Life for PBS.
Mr. Ashley’s Broadway credits include Come From Away (Tony and Outer Critics Circle Awards), Diana: The Musical, Escape to Margaritaville, Memphis (Tony Award nomination), Xanadu, Leap of Faith (Drama Desk Award nomination), All Shook Up and The Rocky Horror Show (Tony, Drama Desk, Outer Critics Circle Award nominations). He also helmed productions of Come From Away in London (Olivier Award nomination), Toronto, Australia and on national tour. Other national tours include Escape to Margaritaville, Memphis, Xanadu, All Shook Up and Seussical: The Musical. Additional New York stage credits include Blown Sideways Through Life, Jeffrey (Lucille Lortel and Obie Awards), The Most Fabulous Story Ever Told, Valhalla (Lucille Lortel Award nomination), Regrets Only, Wonder of the World, Communicating Doors, Bunny Bunny, The Night Hank Williams Died and Fires in the Mirror (Lucille Lortel Award), among others.
Mr. Ashley is the recipient of the Princess Grace Award, the Drama League Director Fellowship and an NEA/TCG Director Fellowship.
Debby Buchholz
Managing Director of La Jolla Playhouse
Debby Buchholz was appointed La Jolla Playhouse’s new Managing Director in 2018 and has served as General Manager of the Playhouse since 2002. She is a member of the Executive Committee of the League of Resident Theaters (LORT). In 2009, she received a San Diego Women Who Mean Business Award from San Diego Business Journal. Previously she served as Counsel to the John F. Kennedy Center for the Performing Arts and the National Symphony Orchestra in Washington, D.C. She was a faculty member of the Smithsonian Institution’s program on Legal Problems of Museum Administration. Prior to the Kennedy Center, she served as a corporate attorney in New York City and Washington, D.C. She is a graduate of UC San Diego and Harvard Law School. Ms. Buchholz and her husband, noted author and White House economic policy advisor Todd Buchholz, live in Solana Beach and are the proud parents of Victoria, Katherine and Alexia.
Denise Bevers
President and CEO, VETmAb Biosciences
As a biotech executive and advisor, Denise has led companies to explosive business growth and raised approximately $500 million in capital both privately and publicly, in addition to bringing life-saving veterinary and human therapeutics to market. Denise is President and CEO of VETmAb Biosciences, a veterinary biopharmaceutical company developing monoclonal antibody (or “mAb”) therapeutics for dogs and cats. Prior to founding VETmAb Bio, Denise served as the COO of DTx Pharma, a biotechnology company creating novel RNA-based therapeutics to treat the genetic drivers of disease. To date, Denise is most proud of her tenure as President and COO of Kindred Biosciences, a veterinary biopharmaceutical company she co-founded in 2012, took public in 2013, and sold to Elanco in 2021. Prior to KindredBio, Denise served as President and Founding Partner of SD Scientific, a full-service medical affairs and communications company, and has held management positions at Elan Pharmaceuticals, SkyePharma, Quintiles, and Scripps Clinic and Research Foundation. Denise is a passionate trustee, executive committee member, and Secretary of La Jolla Playhouse. She also serves on the board of several nonprofits and biotech companies, from CONNECT, which helps innovators and entrepreneurs in Southern California by providing access to investors, mentors, and education, to Hilltop Bio, a Boston-based biotech developing regenerative therapies for animals. Denise earned her B.S. from University of California, San Diego in Ecology, Behavior, and Evolution and holds an M.B.A. from Keller Graduate School of Management.Denise and her husband, Lon, love spending time with their dogs, as well as enjoying live music and travel. They are passionate supporters of theater, both locally and as Broadway investors.
Adam Jacobs
Co-founder, The Jacobs Scheriff Group
Adam is co-founder of The Jacobs Scheriff Group; a business consulting firm whose mission is to add value to companies or organizations whose product or service positively helps society. He believes that impact can come from both for-profit and non-profit arenas. He is the Treasurer for the Lawrence Family Jewish Community Center (JCC), and recently Co-Chaired for the JCC Maccabi Games & ACCESS that brought 1,800 Jewish teens from around the world to San Diego for a week of athletic competition, community service, and learning life lessons through sport; also piloting a program that included both neurotypical and neurodivergent participants together. He is also the Immediate Past Chair of The Board for the Carlsbad Chamber of Commerce. In addition, he is involved in a number of other non-profits including the San Diego Food Bank, San Diego Symphony, Jewish Community Foundation, San Diego Zoo Wildlife Alliance, Jewish Family Service, and other initiatives related to housing, homelessness, and food insecurity. Adam has invested in several startup companies who have an aim at social change. He is a former member of Forward Global (formerly the Philanthropy Workshop) He also owns several real estate rental properties. Adam is a native of San Diego and graduate of Cornell University in 2009 where he was the catcher and three-year captain of the baseball team. He then went on to play baseball professionally throughout the Continental US, Hawaii, and Australia. In his free time, Adam enjoys playing tennis, rooting for the San Diego Padres and Edmonton Oilers. He lives in San Diego with his wife, Amy, daughter Aylana (Ayla), son Arlian (Arli), dogs Zelle, Torrey, and Luno, as well as tortoise, Squirt.
Tim Scott
President and CEO, AustinPx
Mr. Scott is President and CEO of AustinPx, a technology company enhancing the pharmacokinetics of critical medicines. He is the co-founder and Executive Board Chair of TEGA Therapeutics, a glycobiology company focused on lysosomal storage disorders and recombinant heparan sulfates. He previously was co-founder and President of Pharmatek Laboratories, a contract development and manufacturing company (sold to Catalent Pharma Solutions in 2016). Prior to that, he was Senior Vice President at Active.com (IPO 2011). Mr. Scott serves on the Board of Avelas, a bioscience company working to create better outcomes for cancer patients with its activatable cell-penetrating peptide technology. He also serves on the board of DTx, a biotechnology company using fatty acid motifs to deliver RNA therapeutics. He previously served on the board of Zacharon Pharmaceuticals (sold to Biomarin 2014). Mr. Scott has founded or supported multiple spinouts from UC San Diego including Zacharon, TEGA, LipoNexus, Knoubis Bio, Nerio and Augment. Mr. Scott is immediate past Executive Board Chair of CONNECT, a non-profit organization helping to create and scale innovation companies in San Diego. He serves as Chair of BIOCOM, a non-profit organization supporting the needs of bio/pharma companies in California. Mr. Scott serves on the Medical Research Advisory Committee for the Conrad Prebys Foundation, providing grants to innovative research in the health sciences. At UC San Diego, he serves on the Dean’s Advisory Council for the Division of Biological Sciences. In the community, Mr. Scott is a trustee for the La Jolla Playhouse, a Tony-award winning regional theatre. And he serves on the board of Outside the Lens, a non-profit providing photography and digital media programs for underserved youth. Mr. Scott earned his B.A. in Biochemistry from the University of California, San Diego. He earned his J.D. from the University of San Diego and is a member of the California Bar.
Host Committee
Travis Alegria – Branch Sales Manager, Sharp Business Systems
Michalyn Andrews – CEO/Co-founder, Provenance Bio
Andrew Biros – Senior Director, Center for Social Innovation and Entrepreneurship, Office of the Senior Vice President and Provost, University of San Diego
Dan Bradbury – Managing Member, BioBrit, LLC
David A. Brenner, M.D. – President and Chief Executive Officer, Sanford Burnham Prebys
Jennifer Cayer – Chief Business Officer, Pulmocide
Ann Chaplin – General Counsel, Qualcomm
Stephan Coleman – Market Managing Director, Institutional Asset Management, PNC Bank
David Crean – Managing Partner, Cardiff Advisory, LLC
Matt D’Alessandro – Senior Vice President, Corporate Banking, PNC Bank
Brett D’Arcy – Managing Partner, D’Arcy Capital
Ed Dennis – Distinguished Professor of Chemistry, Biochemistry, Pharmacology, and the Graduate Division Chancellor I Endowed Chair School of Medicine, UCSD
Susan Dubé – Board Member, La Jolla Playhouse
Ray Flores – Military and Veterans Affairs Officer, County of San Diego
Jeff Friedman – Managing Partner, Friedman Bioventure
Jenni Friedman – Managing Partner, Friedman Bioventure
Deb Hart – Head of Investor Relations, Maravai LifeSciences
Greg Horowitt – Director of Innovation & Design, UCSD
John Jarvis – Executive Vice President, Hughes Marino
Bryan Knox – General Manager, Catalent
Mike Krenn – President and CEO, Connect
Christopher Lee – Associate Vice Chancellor, University of California San Diego
Courtney Liddy – Managing Director – Wealth Management/Private Wealth Advisor, The Liddy Group
James Mackay – President and CEO, AristeaTX
Hala Madanat – Vice President of Research and Innovation, SDSU
David Marchesani – Founder and CEO, Iapetus Capital, Inc.
Chris Montgomery – SVP, Business Development, CNM LLP
Juli Moran – San Diego Office Marketplace Leader, Deloitte
Tom Murphy – Partner, Calibre One
Joseph Panetta – President and CEO, Biocom California
Christina Romeo – Small Commercial Sales Manager – Los Angeles, The Hanover Insurance Group
Ivor Royston – President and CEO, Carson Royston Group
Tim Schoen – CEO, BioMed Realty
Trent Selbrede – General Manager, Marriott/Residence Inn La Jolla
Natalie Sherod – Risk Advisor, CPCU, CRM, CIC, Cavignac
Scott Stanton – Member, Mintz
Michael Sullivan – Partner, Latham & Watkins
Kelly Thomson – Regional Managing Director, Ascent Private Capital
Erin Trenda – Litigation Partner, Cooley
Mary Walshok – Co-Founder, Connect & UC San Diego Associate Vice Chancellor for Public Programs (Retired), UCSD
Nicola Wilkins-Miller – Director of Philanthropy, Scripps Research